Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13046-019-1342-5.

Title:
The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway | Journal of Experimental & Clinical Cancer Research
Description:
Background Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patients. Therefore, alternative therapeutic targets are urgently needed. Since growing evidence demonstrates that WNT/β-catenin signaling plays an important role in CRPC, the antitumor activity and mechanism of action of CWP232291, a small molecule β-catenin inhibitor, were investigated in prostate cancer. Methods We assessed the antitumor activity of CWP232291 in prostate cancer cell lines and primary cells derived from CRPC patients. The effect of CWP232291 on apoptotic cell death, endoplasmic reticulum (ER) stress, cell viability, and WNT/β-catenin signaling was evaluated by flow cytometry, western blotting, luciferase reporter assay, and fluorescence microscopy. Antitumor efficacy was assessed in two CRPC xenograft mouse models. Results CWP232291 induced ER stress, resulting in upregulation of the proapoptotic protein CHOP and activation of caspase-3-dependent apoptosis. In addition, CWP232291 suppressed the expression of β-catenin by affecting WNT-dependent transcriptional activity, and downregulated AR and its splice variants in prostate cancer cells. Antitumor activity was observed in prostate cancer cells in vitro and ex vivo, and antitumor efficacy was observed in vivo. Conclusions Beyond providing preclinical evidence of therapeutic efficacy for the novel small molecule β-catenin inhibitor CWP232291 in CRPC, our results show that inducing ER stress and targeting WNT/β-catenin signaling may be a novel strategy against CRPC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,603,974 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cwp, cancer, cells, prostate, pubmed, article, cell, βcatenin, google, scholar, wntβcatenin, stress, cas, signaling, lncap, fig, pathway, crpc, protein, wnt, control, exposed, apoptosis, activity, central, growth, assay, induces, study, results, western, expression, analysis, data, endoplasmic, reticulum, androgen, patients, treatment, tumor, performed, mice, stem, inhibitor, lee, viability, forward, reverse, means, castrationresistant,

Topics {✒️}

compound z-valine-alanine-aspartate-fluoromethylketone alters cbp/β-catenin-dependent transcription cell-permeable pan-caspase inhibitor wnt/β-catenin pathway modulators inhibit wnt/β-catenin signaling wnt/β-catenin signaling cascade interferon-α/5-fluorouracil combination therapy wnt/β-catenin signaling pathway wnt/β-catenin signaling modulation wnt/β-catenin inhibitor cwp232291 wnt/β-catenin signaling plays targeting wnt/β-catenin signaling β-catenin-dependent canonical pathway castration-resistant prostate cancer chan-hee park wnt/β-catenin inhibitor castrate-resistant prostate cancer tcf/lef reporter construct jung-hyuck park lef/tcf family members article download pdf wnt/β-catenin pathway wnt/β-catenin pathway [17] wnt/β-catenin signaling beta-catenin/apc pathway hormone-naïve prostate cancer er stress-related markers endoplasmic reticulum stress peptidomimetic small molecule lef/tcf reporter activity wnt/β-catenin inhibition tcf/lef-binding sites β-catenin-dependent transcription [7 metastatic prostate cancer endoplasmic reticulum chaperones article pak induces tumor-selective apoptosis concentration-time profile indicating potent growth-inhibiting optimem® reduced-serum medium favorable safety profile abrogated cwp232291-induced apoptosis cell-free medium wnt signaling pathway wnt pathway modulation kyoung-june lee full access cyclooxygenase-2-independent anticarcinogenic effects central organelle involved cwp232291-treated cell lines

Questions {❓}

  • Targeting Wnt signaling: can we safely eradicate cancer stem cells?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
         description:Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patients. Therefore, alternative therapeutic targets are urgently needed. Since growing evidence demonstrates that WNT/β-catenin signaling plays an important role in CRPC, the antitumor activity and mechanism of action of CWP232291, a small molecule β-catenin inhibitor, were investigated in prostate cancer. We assessed the antitumor activity of CWP232291 in prostate cancer cell lines and primary cells derived from CRPC patients. The effect of CWP232291 on apoptotic cell death, endoplasmic reticulum (ER) stress, cell viability, and WNT/β-catenin signaling was evaluated by flow cytometry, western blotting, luciferase reporter assay, and fluorescence microscopy. Antitumor efficacy was assessed in two CRPC xenograft mouse models. CWP232291 induced ER stress, resulting in upregulation of the proapoptotic protein CHOP and activation of caspase-3-dependent apoptosis. In addition, CWP232291 suppressed the expression of β-catenin by affecting WNT-dependent transcriptional activity, and downregulated AR and its splice variants in prostate cancer cells. Antitumor activity was observed in prostate cancer cells in vitro and ex vivo, and antitumor efficacy was observed in vivo. Beyond providing preclinical evidence of therapeutic efficacy for the novel small molecule β-catenin inhibitor CWP232291 in CRPC, our results show that inducing ER stress and targeting WNT/β-catenin signaling may be a novel strategy against CRPC.
         datePublished:2019-08-06T00:00:00Z
         dateModified:2019-10-31T00:00:00Z
         pageStart:1
         pageEnd:13
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13046-019-1342-5
         keywords:
            Prostate cancer
            Castration-resistant
            WNT signaling pathway
            Endoplasmic reticulum stress
            Cancer Research
            Immunology
            Apoptosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig6_HTML.png
         isPartOf:
            name:Journal of Experimental & Clinical Cancer Research
            issn:
               1756-9966
            volumeNumber:38
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sahyun Pak
               affiliation:
                     name:Center for Urologic Cancer, National Cancer Center
                     address:
                        name:Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sejun Park
               affiliation:
                     name:University of Ulsan College of Medicine, Ulsan University Hospital
                     address:
                        name:Department of Urology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yunlim Kim
               affiliation:
                     name:University of Ulsan College of Medicine, Asan Medical Center
                     address:
                        name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
                        type:PostalAddress
                     type:Organization
                     name:Asan Institute for Life Science, Asan Medical Center
                     address:
                        name:Asan Institute for Life Science, Asan Medical Center, Seoul, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jung-Hyuck Park
               affiliation:
                     name:Drug Discovery Center, JW Pharmaceutical Corporation
                     address:
                        name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chan-Hee Park
               affiliation:
                     name:Drug Discovery Center, JW Pharmaceutical Corporation
                     address:
                        name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kyoung-June Lee
               affiliation:
                     name:JW Creagene Corporation
                     address:
                        name:JW Creagene Corporation, Seongnam, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Choung-soo Kim
               affiliation:
                     name:University of Ulsan College of Medicine, Asan Medical Center
                     address:
                        name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hanjong Ahn
               affiliation:
                     name:University of Ulsan College of Medicine, Asan Medical Center
                     address:
                        name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
      description:Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patients. Therefore, alternative therapeutic targets are urgently needed. Since growing evidence demonstrates that WNT/β-catenin signaling plays an important role in CRPC, the antitumor activity and mechanism of action of CWP232291, a small molecule β-catenin inhibitor, were investigated in prostate cancer. We assessed the antitumor activity of CWP232291 in prostate cancer cell lines and primary cells derived from CRPC patients. The effect of CWP232291 on apoptotic cell death, endoplasmic reticulum (ER) stress, cell viability, and WNT/β-catenin signaling was evaluated by flow cytometry, western blotting, luciferase reporter assay, and fluorescence microscopy. Antitumor efficacy was assessed in two CRPC xenograft mouse models. CWP232291 induced ER stress, resulting in upregulation of the proapoptotic protein CHOP and activation of caspase-3-dependent apoptosis. In addition, CWP232291 suppressed the expression of β-catenin by affecting WNT-dependent transcriptional activity, and downregulated AR and its splice variants in prostate cancer cells. Antitumor activity was observed in prostate cancer cells in vitro and ex vivo, and antitumor efficacy was observed in vivo. Beyond providing preclinical evidence of therapeutic efficacy for the novel small molecule β-catenin inhibitor CWP232291 in CRPC, our results show that inducing ER stress and targeting WNT/β-catenin signaling may be a novel strategy against CRPC.
      datePublished:2019-08-06T00:00:00Z
      dateModified:2019-10-31T00:00:00Z
      pageStart:1
      pageEnd:13
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13046-019-1342-5
      keywords:
         Prostate cancer
         Castration-resistant
         WNT signaling pathway
         Endoplasmic reticulum stress
         Cancer Research
         Immunology
         Apoptosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-019-1342-5/MediaObjects/13046_2019_1342_Fig6_HTML.png
      isPartOf:
         name:Journal of Experimental & Clinical Cancer Research
         issn:
            1756-9966
         volumeNumber:38
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sahyun Pak
            affiliation:
                  name:Center for Urologic Cancer, National Cancer Center
                  address:
                     name:Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sejun Park
            affiliation:
                  name:University of Ulsan College of Medicine, Ulsan University Hospital
                  address:
                     name:Department of Urology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yunlim Kim
            affiliation:
                  name:University of Ulsan College of Medicine, Asan Medical Center
                  address:
                     name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
                     type:PostalAddress
                  type:Organization
                  name:Asan Institute for Life Science, Asan Medical Center
                  address:
                     name:Asan Institute for Life Science, Asan Medical Center, Seoul, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jung-Hyuck Park
            affiliation:
                  name:Drug Discovery Center, JW Pharmaceutical Corporation
                  address:
                     name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chan-Hee Park
            affiliation:
                  name:Drug Discovery Center, JW Pharmaceutical Corporation
                  address:
                     name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kyoung-June Lee
            affiliation:
                  name:JW Creagene Corporation
                  address:
                     name:JW Creagene Corporation, Seongnam, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Choung-soo Kim
            affiliation:
                  name:University of Ulsan College of Medicine, Asan Medical Center
                  address:
                     name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hanjong Ahn
            affiliation:
                  name:University of Ulsan College of Medicine, Asan Medical Center
                  address:
                     name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Experimental & Clinical Cancer Research
      issn:
         1756-9966
      volumeNumber:38
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Center for Urologic Cancer, National Cancer Center
      address:
         name:Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, South Korea
         type:PostalAddress
      name:University of Ulsan College of Medicine, Ulsan University Hospital
      address:
         name:Department of Urology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, South Korea
         type:PostalAddress
      name:University of Ulsan College of Medicine, Asan Medical Center
      address:
         name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
         type:PostalAddress
      name:Asan Institute for Life Science, Asan Medical Center
      address:
         name:Asan Institute for Life Science, Asan Medical Center, Seoul, South Korea
         type:PostalAddress
      name:Drug Discovery Center, JW Pharmaceutical Corporation
      address:
         name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
         type:PostalAddress
      name:Drug Discovery Center, JW Pharmaceutical Corporation
      address:
         name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
         type:PostalAddress
      name:JW Creagene Corporation
      address:
         name:JW Creagene Corporation, Seongnam, South Korea
         type:PostalAddress
      name:University of Ulsan College of Medicine, Asan Medical Center
      address:
         name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
         type:PostalAddress
      name:University of Ulsan College of Medicine, Asan Medical Center
      address:
         name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sahyun Pak
      affiliation:
            name:Center for Urologic Cancer, National Cancer Center
            address:
               name:Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, South Korea
               type:PostalAddress
            type:Organization
      name:Sejun Park
      affiliation:
            name:University of Ulsan College of Medicine, Ulsan University Hospital
            address:
               name:Department of Urology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, South Korea
               type:PostalAddress
            type:Organization
      name:Yunlim Kim
      affiliation:
            name:University of Ulsan College of Medicine, Asan Medical Center
            address:
               name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
               type:PostalAddress
            type:Organization
            name:Asan Institute for Life Science, Asan Medical Center
            address:
               name:Asan Institute for Life Science, Asan Medical Center, Seoul, South Korea
               type:PostalAddress
            type:Organization
      name:Jung-Hyuck Park
      affiliation:
            name:Drug Discovery Center, JW Pharmaceutical Corporation
            address:
               name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
               type:PostalAddress
            type:Organization
      name:Chan-Hee Park
      affiliation:
            name:Drug Discovery Center, JW Pharmaceutical Corporation
            address:
               name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
               type:PostalAddress
            type:Organization
      name:Kyoung-June Lee
      affiliation:
            name:JW Creagene Corporation
            address:
               name:JW Creagene Corporation, Seongnam, South Korea
               type:PostalAddress
            type:Organization
      name:Choung-soo Kim
      affiliation:
            name:University of Ulsan College of Medicine, Asan Medical Center
            address:
               name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
               type:PostalAddress
            type:Organization
      name:Hanjong Ahn
      affiliation:
            name:University of Ulsan College of Medicine, Asan Medical Center
            address:
               name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, South Korea
      name:Department of Urology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, South Korea
      name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
      name:Asan Institute for Life Science, Asan Medical Center, Seoul, South Korea
      name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
      name:Drug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea
      name:JW Creagene Corporation, Seongnam, South Korea
      name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
      name:Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea

External Links {🔗}(186)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.45s.